268 related articles for article (PubMed ID: 28929861)
1. Ulipristal Acetate and Extracellular Matrix Production in Human Leiomyomas In Vivo: A Laboratory Analysis of a Randomized Placebo Controlled Trial.
Cox J; Malik M; Britten J; Lewis T; Catherino WH
Reprod Sci; 2018 Feb; 25(2):198-206. PubMed ID: 28929861
[TBL] [Abstract][Full Text] [Related]
2. Ulipristal acetate decreases active TGF-β3 and its canonical signaling in uterine leiomyoma via two novel mechanisms.
Lewis TD; Malik M; Britten J; Parikh T; Cox J; Catherino WH
Fertil Steril; 2019 Apr; 111(4):806-815.e1. PubMed ID: 30871768
[TBL] [Abstract][Full Text] [Related]
3. Ulipristal acetate induces cell cycle delay and remodeling of extracellular matrix.
Shin SJ; Kim J; Lee S; Baek J; Lee JE; Cho C; Ha E
Int J Mol Med; 2018 Oct; 42(4):1857-1864. PubMed ID: 30015921
[TBL] [Abstract][Full Text] [Related]
4. Autophagy up-regulation by ulipristal acetate as a novel target mechanism in the treatment of uterine leiomyoma: an in vitro study.
Del Bello B; Marcolongo P; Ciarmela P; Sorbi F; Petraglia F; Luisi S; Maellaro E
Fertil Steril; 2019 Dec; 112(6):1150-1159. PubMed ID: 31843092
[TBL] [Abstract][Full Text] [Related]
5. Gonadotropin-releasing hormone analogues inhibit leiomyoma extracellular matrix despite presence of gonadal hormones.
Malik M; Britten J; Cox J; Patel A; Catherino WH
Fertil Steril; 2016 Jan; 105(1):214-24. PubMed ID: 26409322
[TBL] [Abstract][Full Text] [Related]
6. Steroid hormones and hormone antagonists regulate the neural marker neurotrimin in uterine leiomyoma.
Parikh TP; Malik M; Britten J; Aly JM; Pilgrim J; Catherino WH
Fertil Steril; 2020 Jan; 113(1):176-186. PubMed ID: 32033718
[TBL] [Abstract][Full Text] [Related]
7. Ulipristal Acetate Mediates Decreased Proteoglycan Expression Through Regulation of Nuclear Factor of Activated T-Cells (NFAT5).
Britten JL; Malik M; Lewis TD; Catherino WH
Reprod Sci; 2019 Feb; 26(2):184-197. PubMed ID: 30567472
[TBL] [Abstract][Full Text] [Related]
8. Ulipristal Acetate for Treatment of Uterine Leiomyomas: A Randomized Controlled Trial.
Liu JH; Soper D; Lukes A; Gee P; Kimble T; Kroll R; Mallick M; Chan A; Gillard P; Harrington A; Sniukiene V; Shulman LP
Obstet Gynecol; 2018 Nov; 132(5):1241-1251. PubMed ID: 30303900
[TBL] [Abstract][Full Text] [Related]
9. Ulipristal acetate modulates the expression and functions of activin a in leiomyoma cells.
Ciarmela P; Carrarelli P; Islam MS; Janjusevic M; Zupi E; Tosti C; Castellucci M; Petraglia F
Reprod Sci; 2014 Sep; 21(9):1120-5. PubMed ID: 25001022
[TBL] [Abstract][Full Text] [Related]
10. Health-Related Quality of Life With Ulipristal Acetate for Treatment of Uterine Leiomyomas: A Randomized Controlled Trial.
Lukes AS; Soper D; Harrington A; Sniukiene V; Mo Y; Gillard P; Shulman L
Obstet Gynecol; 2019 May; 133(5):869-878. PubMed ID: 30969201
[TBL] [Abstract][Full Text] [Related]
11. Changes in proliferating and apoptotic markers of leiomyoma following treatment with a selective progesterone receptor modulator or gonadotropin-releasing hormone agonist.
Yun BS; Seong SJ; Cha DH; Kim JY; Kim ML; Shim JY; Park JE
Eur J Obstet Gynecol Reprod Biol; 2015 Aug; 191():62-7. PubMed ID: 26093349
[TBL] [Abstract][Full Text] [Related]
12. Liarozole inhibits transforming growth factor-β3--mediated extracellular matrix formation in human three-dimensional leiomyoma cultures.
Levy G; Malik M; Britten J; Gilden M; Segars J; Catherino WH
Fertil Steril; 2014 Jul; 102(1):272-281.e2. PubMed ID: 24825427
[TBL] [Abstract][Full Text] [Related]
13. Matrix Metalloproteinase Activity Correlates With Uterine Myoma Volume Reduction After Ulipristal Acetate Treatment.
Courtoy GE; Henriet P; Marbaix E; de Codt M; Luyckx M; Donnez J; Dolmans MM
J Clin Endocrinol Metab; 2018 Apr; 103(4):1566-1573. PubMed ID: 29408988
[TBL] [Abstract][Full Text] [Related]
14. Individualized vaginal bleeding experience of women with uterine fibroids in the PEARL I randomized controlled trial comparing the effects of ulipristal acetate or placebo.
Barlow DH; Lumsden MA; Fauser BC; Terrill P; Bestel E
Hum Reprod; 2014 Mar; 29(3):480-9. PubMed ID: 24457604
[TBL] [Abstract][Full Text] [Related]
15. Locostatin, a disrupter of Raf kinase inhibitor protein, inhibits extracellular matrix production, proliferation, and migration in human uterine leiomyoma and myometrial cells.
Janjusevic M; Greco S; Islam MS; Castellucci C; Ciavattini A; Toti P; Petraglia F; Ciarmela P
Fertil Steril; 2016 Nov; 106(6):1530-1538.e1. PubMed ID: 27565262
[TBL] [Abstract][Full Text] [Related]
16. Leiomyoma fibrosis inhibited by liarozole, a retinoic acid metabolic blocking agent.
Gilden M; Malik M; Britten J; Delgado T; Levy G; Catherino WH
Fertil Steril; 2012 Dec; 98(6):1557-62. PubMed ID: 22925684
[TBL] [Abstract][Full Text] [Related]
17. Tranilast, an orally active antiallergic compound, inhibits extracellular matrix production in human uterine leiomyoma and myometrial cells.
Islam MS; Protic O; Ciavattini A; Giannubilo SR; Tranquilli AL; Catherino WH; Castellucci M; Ciarmela P
Fertil Steril; 2014 Aug; 102(2):597-606. PubMed ID: 24934492
[TBL] [Abstract][Full Text] [Related]
18. Versican Proteolysis by ADAMTS Proteases and Its Influence on Sex Steroid Receptor Expression in Uterine Leiomyoma.
Gueye NA; Mead TJ; Koch CD; Biscotti CV; Falcone T; Apte SS
J Clin Endocrinol Metab; 2017 May; 102(5):1631-1641. PubMed ID: 28323982
[TBL] [Abstract][Full Text] [Related]
19. Ulipristal acetate decreases transforming growth factor β3 serum and tumor tissue concentrations in patients with uterine fibroids.
Ciebiera M; Włodarczyk M; Wrzosek M; Słabuszewska-Jóźwiak A; Nowicka G; Jakiel G
Fertil Steril; 2018 Mar; 109(3):501-507.e2. PubMed ID: 29525690
[TBL] [Abstract][Full Text] [Related]
20. Myometrial cells undergo fibrotic transformation under the influence of transforming growth factor beta-3.
Joseph DS; Malik M; Nurudeen S; Catherino WH
Fertil Steril; 2010 Mar; 93(5):1500-8. PubMed ID: 19328471
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
